CND Life Sciences
CND Life Sciences is a medical technology company offering cutaneous testing and biomarker services for neurodegenerative disorders. The Syn-One Test® detects, visualizes, and quantifies misfolded alpha-synuclein in cutaneous nerves with greater than 95% sensitivity and specificity to aid in the diagnosis of Parkinson’s disease and related disorders. The test utilizes a simple in-office skin biopsy procedure to provide clinicians and patients with unique pathological insights as early in the disease process as possible. CND collaborates with biopharmaceutical companies to help optimize clinical trials for investigational drugs by quantifying alpha-synuclein in cutaneous nerves and measuring its volume over time with assistance from the company’s NerValence AI-based system.
